Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Short-term Investments (2020 - 2023)

IceCure Medical (ICCM) has disclosed Short-term Investments for 3 consecutive years, with $529000.0 as the latest value for Q4 2023.

  • On a quarterly basis, Short-term Investments rose 78.72% to $529000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $529000.0, a 78.72% increase, with the full-year FY2023 number at $529000.0, up 78.72% from a year prior.
  • Short-term Investments was $529000.0 for Q4 2023 at IceCure Medical, up from $296000.0 in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $4.7 million in Q4 2020 to a low of $296000.0 in Q4 2022.
  • A 3-year average of $1.8 million and a median of $529000.0 in 2023 define the central range for Short-term Investments.
  • Biggest YoY gain for Short-term Investments was 78.72% in 2023; the steepest drop was 78.72% in 2023.
  • IceCure Medical's Short-term Investments stood at $4.7 million in 2020, then crashed by 93.66% to $296000.0 in 2022, then soared by 78.72% to $529000.0 in 2023.
  • Per Business Quant, the three most recent readings for ICCM's Short-term Investments are $529000.0 (Q4 2023), $296000.0 (Q4 2022), and $4.7 million (Q4 2020).